ERS 2020

Date
Date Format: DD slash MM slash YYYY
Family Name*
First Name*
Specialty*
City*
6-September
- General pneumology
- Respiratory intensive care
- Basic and translational sciences
- Sleep and breathing disorders; and clinical physiology
- Airway diseases, asthma and COPD
- Epidemiology and environment
- Paediatrics
- Allied respiratory professionals
- Respiratory infections
- Thoracic oncology
- Interstitial lung diseases
- Pulmonary vascular diseases
- COVID-19
- Epidemiology
- Impact in children and in adults with premorbid respiratory disease (acute and long-term)
- Keynote COVID-19 – recapitulation
- Management
- Management prevention
- Post-COVID
7-September
- Airflow obstruction, COPD and comorbidities
- Airway diseases
- ALERT Infection in adults and children
- Application of home ventilation
- Asthma pharmacology clinical trials and mechanistic insights
- Biological aspects of lung cancer
- Breathing disorders and cardiovascular diseases
- Bronchiectasis
- Challenging issues in thoracic surgery
- Chinese programme 2020 Part I
- Chronic respiratory diseases and their origins in early life
- Course and Management of Fibrosing ILDs
- Covering COVID - the best abstracts
- Diagnosis and management of airways
- Dupilumab in Severe Asthma
- Early prevention
- Elevate the Standard in Endobronchial Lung Cancer Diagnosis and Staging
- European Reference Network for rare lung diseases
- Everything you always wanted to know about COPD
- Exercise and sleep from impaired function to new therapeutic strategies
- Frontiers of lung cancer screening
- Hot topics in pediatric asthma
- How to overcome deficiencies in skills in bedside training by virtual tools and simulation- where do we go
- Image-based guidelines and recommendations in respiratory diseases
- Imaging grand round
- Innovations in airway innervation
- Interstitial lung diseases
- Interstitial lung diseases-2
- Is the global warming potential
- Lung cancer screening
- Lung health and respiratory function at all ages
- Management of the endoscopy suite under new parameter Your Freedom of Choice
- Maximizing the benefits of inhaled therapies in asthma
- Mepolizumab Precision medicine in eosinophilic inflammation
- Metabolic alterations and ageing in lung disease
- New and integrated tools for respiratory diagnosis and care
- New clinical insights into idiopathic pulmonary fibrosis
- New developments in pandemic medical
- New insights into asthma immunology in mouse and men
- New insights into mechanical ventilation in the intensive care unit
- New technologies for the management of COPD
- Novel methods, diagnostics and biomarkers of chronic lung diseases
- Pediatric procedures
- Pediatric respiratory diseases
- Physical activity
- Pulmonary vascular diseases
- Relationg osc to last resort
- Respiratory critical care
- Respiratory infections
- Respiratory physiology and sleep
- Rethinking asthma
- Rheumatology
- Right ventricular function
- SABA status quo state of emergency from policy to patient
- Screening and imaging in lung cancer
- Severe thoracic sarcoidosis
- Single-use bronchoscopes PENTAX Medical developing the Freedom of Choice
- Sleep and breathing disorders
- Successful inhalation therapy in 2020 patients and inhalers in focus
- The European Respiratory Journal
- The new reality
- The Treatment of Severe Respiratory Disorders in Challenging Times
- Time for change Pioneering in IPF management
- Treatable traits
- Updated assessment and treatment
- Updates in cystic fibrosis
- Use of thoracic ultrasound in different clinical settings
- What is the evidence
- What will the decade bring in new treatment options for ILD patients?
- Which pediatric asthma guidelines
- Will the pulmonologist still play a role
- Workplace and outdoor air quality from sensitization to social media
- www.RethinkNTM Who, Why and When
8-September
- (Re-)discovering the small airway epithelium in COVID-19
- Advances in cystic fibrosis
- Air pollution and interstitial lung disease
- Airway diseases
- ALERT Asthma in adults and children
- ALERT Ventilation and rehabilitation
- Antibiotic therapy for pneumonia and pleural infections
- Aspects of acute and chronic airway infections in children
- Best abstracts in the field of pulmonary rehabilitation
- Bronchoscopy and endosonography
- Bronchoscopy and ultrasound Interstitial and pleural diseases
- Bugs secret's the way the microbiome changes our future
- Cardiovascular morbidity and mortality after pulmonary embolism
- Cellular involvement in lung injury
- Chinese programme 2020 Part II
- Chronic cough only symptom or disease
- Clinical Considerations for Targeting Type 2 Inflammation in Upper and Lower Airway Diseases
- Clinical grand round revisiting current guidelines
- Connected inhalers and communication
- COPD and Air Leak treatment - Master Challenging Cases with Spiration Bronchial Valves
- COPD treatment What is the most important target
- Cutting edge science novel molecules and mechanisms of airway diseases
- Cystic fibrosis from cradle to old age
- Diagnosis and management of asthma
- Digital technologies in airway diseases
- Don't blame your parents
- Epithelial cytokines in the airway recent advances in severe asthma
- Exciting new developments in lung cancer screening
- Exploring respiratory function
- Fear and anxiety
- French program 2020 Part I
- From tobacco and vaping health effects to tobacco cessation
- Frontiers in eosinophilic diseases
- Genetics and genomics of pulmonary arterial hypertension
- German program 2020
- How do different treatment strategies translate into costs
- How much lung disease is really caused by work, and how to assess the worker who wishes to continue working
- Human ex vivo models of interstitial lung disease
- Lung epithelial development and repair in three-dimensions
- Lung transplantation in the era of new drugs
- Malignant pleural effusion in 2020
- Management of recurrent pediatric respiratory tract infections and complications a missed opportunity
- Mind the gap evidence on the treatment of alpha-1 antitrypsin deficiency and unmet needs
- Muscle, exercise capacity and symptoms of chronic lung disease a physio update
- Nasal high flow and non-invasive ventilation in acute and chronic care
- Nasal High Flow Non Invasive Respiratory Support for COVID-19 Patients
- New biomarkers for management of obstructive diseases
- New clinical and real-world data to inform treatment choices in COPD
- New frontiers in cystic fibrosis imaging and lung physiology
- Pediatric respiratory diseases
- Part I From symptoms to diagnosis in primary care
- Part II From symptoms to diagnosis in primary care
- Personal strategies to minimise effects of air pollution on respiratory health
- Pneumothorax to drain or not to drain
- Precision endotyping of asthma
- Pulmonary vascular diseases
- Pulmonary vascular diseases2
- Quantitative imaging in diffuse lung disease
- Real-World Data from Patients with ILDs
- Reducing the burden of asthma
- Reflections from the Lung Science 2020 conference
- Respiratory critical care
- Respiratory disorders in neonatal and paediatric intensive care units ventilation and chronic conditions
- Respiratory infections
- Sarcoidosis from genetics to epidemiology
- Science is no illusion extrafine combination therapy in asthma and COPD
- Severe allergic asthma management in children
- Severe asthma and co-morbid nasal polyposis a patient-centric approach
- Successful inhalation therapy in 2020
- Supporting the patient pathway in ILD management
- The ageing lung epithelium effects on repair and regeneration
- The impact of different treatment modalities on obstructive sleep apnoea
- Treatments and biomarkers for lung allograft function and outcome
- Tuberculosis learning from the WHO global health emergencies
- Tuberculosis part 1
- Waking and walking with COPD Inhalation matters
- What is new in interstitial lung diseases of known origin
- When the lung gets stiff
9-September
- Advances in pharmacological treatment of COPD
- Ageing, metabolic syndrome and the lung
- Air pollution and COVID-19 what we know, what we need to know
- Airway development in health and disease
- Airway diseases
- Airway infection the microbiome and beyond
- Case discussions What do we do with ILD patients with more advanced functional impairment
- Community acquired pneumonia new guidelines, major advances
- Continuity of care for patients with OSA or Chronic Respiratory Failure post-pandemic
- Digital health a brave new world
- Do I need a robot in my thoracic surgery operating theatre
- Does exposure long before conception influence future respiratory health
- Early career member activities, opportunities and motivations
- E-cigarette or Vaping, product use Associated Lung Injury (EVALI)
- Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
- Endobronchial Valves for Successful Treatment of Severe Lung Emphysema From Optimal Patient Selection to Complications Management
- French programme 2020 Part II
- From diagnosis to management of pulmonary embolism
- Genetic and environmental influences on development of asthma and COPD
- Hot topics in intensive care COVID-19 Lessons learned
- Improving pulmonary fibrosis diagnosis and care in Europe
- Improving the delivery of tobacco-use treatment
- Industry lunchtime symposium
- Inhalers for COPD and asthma reviews
- Insights from wearable respiratory sensors and AI
- Interstitial lung disease patients in the intensive care unit
- Interstitial lung diseases
- Lung cancer grand round
- Lung cancer screening is it ready for implementation
- Management of Autoimmune Disease-Related ILDs How Can We Improve Outcomes for Patients
- Managing frailty in patients with acute or chronic lung disorders
- Navigating Treatment Decisions for Patients With Uncontrolled Severe Asthma A New Understanding of Type 2 Inflammation
- Noninvasive respiratory assistance for acute respiratory failure outside the intensive care unit a bargain or a burden
- Novel insights into nursing interventions for managing patients with asthma and COPD
- Novelties in interventional pulmonology expanding horizons
- Novelties in pulmonary rehabilitation and chronic respiratory care
- Origins of respiratory diseases do early life exposure and diet really matter
- Paediatric grand round
- Paediatric respiratory diseases
- Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
- Prediction and management of outcomes in obstructive diseases
- PRESENTATION
- Promising biomarkers for idiopathic interstitial pneumonia
- Protecting the planet time for action!
- Recent innovations regarding the mechanisms and treatments of asthma
- Remote monitoring of patients with Respiratory Failure receiving Home Mechanical Ventilation
- Respiratory critical care
- Respiratory infections
- Russian speaking programme 2020 Part I
- Russian speaking programme 2020 Part II
- Severe asthma phenotypes and outcomes
- Severe eosinophilic asthma in the biologic era From clinical studies to clinical practice
- Skills training and assessment in pulmonary medicine and surgery
- SpanishPortuguese program 2020 Part I
- SpanishPortuguese program 2020 Part II
- STAND UP AGAINST COPD A hit Hard, or hit Right approach
- The future of bronchiectasis management
- The Lung, at the Heart of Pulmonary Arterial Hypertension
- Thoracic oncology
- Thoracic oncology2
- Tip the hat to pediatric bronchology
- Tuberculosis part 2
- Using Syndromic Testing to accelerate patient management decisions in respiratory tract infection suspicions during the COVID-19 crisis
- What would you recommend
- What’s new with ground-glass opacities
- Which target to protect and preserve lungs health

واژه یا عبارت مورد نظر خود را تایپ کنید و سپس بر روی Enter کلیک کنید.